Stock Evaluator: ZIVO Bioscience, Inc. (ZIVO)

ZIVO Bioscience, Inc. ZIVO

$3.95 0.00 0.00%
September 3, 2026 9:30:07 AM EST November 10, 2021 Volume: 198
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD | DELAYED PRICE
SECTOR INDUSTRY
Consumer Staples Personal Care Products

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Commentary & Analysis


Financial Summary

Share Statistics ZIVO Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $16.4 $250.3 9%
Shares Out (Mil) 3.8 32.8 12%
Institutional Ownership 0.3% 58.3% 1%
Float (Mil) 1.6 37.8 4%
Beta 0.11 0.56 9%
Avg Daily Volume (000s) 1 114 4%
Price Change
(52-week)
(81.2%) 57.2% 6%
Growth ZIVO Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 0.9% na
Net Income (5yr) (3.1%) (7.5%) 36%
EPS (5yr) 26.7% (0.2%) 77
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) 50.5% (14.9%) 93%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials ZIVO Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $0 $571 0%
Net Income (TTM) (Mil) ($9) ($1) 30%
EPS (TTM) ($2.275) $0.000 13%
Operating Cash Flow (TTM) (Mil) ($3) $25 27%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $0 $42 12%
Enterprise Value (Q1) (Mil) $18 $346 10%
Valuation ZIVO Industry
Median
Percentile
(All Stocks)
P/B na 2.00 na
P/E na 16.3 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 0.6 na
Ratios ZIVO Industry
Median
Percentile
(All Stocks)
Gross Margin 31.7% 62.9% 37%
Net Margin na 1.2% na
ROA na (1.5%) na
ROE 316.1% 4.8% 99%
Liabilities to Assets 687.5% 49.5% 100%
F-Score 1 4 1%

ZIVO Bioscience, Inc. did not pass any screens on 9/2/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors